148 related articles for article (PubMed ID: 37468132)
1. Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review.
Veltsista PD; Oberacker E; Ademaj A; Corradini S; Eckert F; Flörcken A; Kaul D; Lindner LH; Issels R; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Roohani S; Spalek MJ; Riesterer O; Zips D; Ghadjar P
Int J Hyperthermia; 2023; 40(1):2236337. PubMed ID: 37468132
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Issels RD; Prenninger SW; Nagele A; Boehm E; Sauer H; Jauch KW; Denecke H; Berger H; Peter K; Wilmanns W
J Clin Oncol; 1990 Nov; 8(11):1818-29. PubMed ID: 2121910
[TBL] [Abstract][Full Text] [Related]
3. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia in soft tissue sarcoma.
Lindner LH; Issels RD
Curr Treat Options Oncol; 2011 Mar; 12(1):12-20. PubMed ID: 21360087
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
Gellermann J; Hildebrandt B; Issels R; Ganter H; Wlodarczyk W; Budach V; Felix R; Tunn PU; Reichardt P; Wust P
Cancer; 2006 Sep; 107(6):1373-82. PubMed ID: 16902986
[TBL] [Abstract][Full Text] [Related]
6. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Issels RD; Mittermüller J; Gerl A; Simon W; Ortmaier A; Denzlinger C; Sauer H; Wilmanns W
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S141-7. PubMed ID: 1795003
[TBL] [Abstract][Full Text] [Related]
7. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives.
Seifert G; Budach V; Keilholz U; Wust P; Eggert A; Ghadjar P
Radiat Oncol; 2016 Apr; 11():65. PubMed ID: 27138749
[TBL] [Abstract][Full Text] [Related]
8. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
9. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A; Agaimy A; Fechner K; Ott O; Denz A; Weissmann T; Meidenbauer N; Höfler D; Gaipl U; Frey B; Schmidt M; Haller F; Horch R; Hartmann A; Grützmann R; Fietkau R; Semrau S
Int J Hyperthermia; 2023; 40(1):2248424. PubMed ID: 37611915
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Wendtner C; Abdel-Rahman S; Baumert J; Falk MH; Krych M; Santl M; Hiddemann W; Issels RD
Eur J Cancer; 2001 Sep; 37(13):1609-16. PubMed ID: 11527685
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison.
Zschaeck S; Wust P; Melcher I; Nadobny J; Rau D; Striefler J; Pahl S; Flörcken A; Kunitz A; Ghadjar P
Int J Hyperthermia; 2018; 35(1):1-9. PubMed ID: 30300018
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.
Angele MK; Albertsmeier M; Prix NJ; Hohenberger P; Abdel-Rahman S; Dieterle N; Schmidt M; Mansmann U; Bruns CJ; Issels RD; Jauch KW; Lindner LH
Ann Surg; 2014 Nov; 260(5):749-54; discussion 754-6. PubMed ID: 25379845
[TBL] [Abstract][Full Text] [Related]
14. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Issels RD; Abdel-Rahman S; Wendtner C; Falk MH; Kurze V; Sauer H; Aydemir U; Hiddemann W
Eur J Cancer; 2001 Sep; 37(13):1599-608. PubMed ID: 11527684
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).
Merten R; Ott O; Haderlein M; Bertz S; Hartmann A; Wullich B; Keck B; Kühn R; Rödel CM; Weiss C; Gall C; Uter W; Fietkau R
Oncologist; 2019 Dec; 24(12):e1341-e1350. PubMed ID: 31292267
[TBL] [Abstract][Full Text] [Related]
18. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
[TBL] [Abstract][Full Text] [Related]
19. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
[TBL] [Abstract][Full Text] [Related]
20. Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions.
Issels R; Lindner LH
Curr Opin Oncol; 2016 Sep; 28(5):447-52. PubMed ID: 27455134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
